Claim: Can vitamin B2 help cancer cells survive longer by protecting them from cell death?

First requested: May 17, 2026 at 7:06 AM
72%

IsItCap Score

Truth Potential Meter

Generally Credible

AI consensusWeak

Grader consensus is weak.
Range 65%–82% (spread Δ17).
The graders diverge. Treat the combined score as uncertain and read the sources carefully.
Read analysis summary

OpenAI Grade

0%
20%
40%
60%
80%
70%

Perplexity Grade

0%
20%
40%
60%
80%
82%

Google Gemini Grade

0%
20%
40%
60%
80%
65%
Shareable summary
Verdict: Questionable
  • A study found B2 increased cancer cell death with vitamin C.
  • A review says riboflavin can promote apoptosis in cancer contexts.
/r/fact-check-vitamin-b2-cancer-cell-survival

Analysis Summary

Vitamin B2 can help cancer cells survive longer by protecting them from cell death, particularly through its role in resisting ferroptosis. Research from various studies supports this claim, indicating that vitamin B2 metabolism contributes to cancer cell resistance. However, some studies suggest that vitamin B2 may also promote cell death under certain conditions, which complicates the overall understanding of its effects on cancer cells. Critics argue that the relationship is not straightforward and can vary based on context and treatment combinations. The graders interpret the evidence differently, so the score range widens. Perplexity comes in highest (82%), while Gemini is lowest (65%). While several studies indicate that vitamin B2 supports cancer cell survival by protecting against ferroptosis, opposing evidence shows that it can also enhance cancer cell death when combined with other treatments, such as vitamin C. This dual role raises questions about the consistency of vitamin B2's effects on cancer cells. The presence of conflicting studies suggests that the claim may hold true in specific contexts but not universally, leading to uncertainty about its overall impact on cancer cell survival.

Source quality

Truth (from sources)7.00 / 10
Source reliability6.00 / 10
Source independence5.00 / 10

Claim checks

Fits established facts7.00 / 10
Logical consistency6.00 / 10
Expert consensus6.00 / 10

Source Analysis

Common arguments
Supporting the claim
  • Reports link riboflavin to FSP1, a pathway that protects cells from ferroptosis.
  • Cancer cell models became more vulnerable when vitamin B2 was deficient.
  • Multiple summaries say targeting B2 metabolism may weaken tumor defenses.
Against the claim
  • A study found B2 increased cancer cell death with vitamin C.
  • A review says riboflavin can promote apoptosis in cancer contexts.
  • Effects may depend on treatment, dose, and cell type, not general survival.

Mainstream Sources

Publication

scitechdaily.com

Title

Vitamin B2's Dark Side: The Nutrient That May Help Cancer Cells Survive

Summary

Reports on research indicating vitamin B2 (riboflavin) helps cancer cells resist ferroptosis, a form of programmed cell death, by supporting the FSP1 pathway.

Source details

Publication

medicalxpress.com

Title

How vitamin B2 could pave the way to new cancer therapies

Summary

Summarizes a Nature Cell Biology study finding that vitamin B2 metabolism contributes to cancer cell resistance to ferroptosis and may be a therapeutic target.

Source details

Publication

uni-wuerzburg.de

Title

How vitamin B2 could pave the way new cancer therapies

Summary

University of Würzburg release describing experimental work linking vitamin B2 to cancer cell survival via ferroptosis resistance.

Source details

Alternative Sources

Publication

pubs.acs.org

Title

Vitamin B2 Sensitizes Cancer Cells to Vitamin-C-Induced Cell Death

Summary

Finds the opposite effect in a different context: vitamin B2 increased cancer cell death when combined with vitamin C, rather than helping cells survive.

Source details

Publication

pmc.ncbi.nlm.nih.gov

Title

Recent Advances on the Role of B Vitamins in Cancer Prevention ...

Summary

Review describing riboflavin as having multiple anti-cancer roles, including regulating ROS, promoting apoptosis, and improving chemotherapy effects, which complicates any simple claim that it helps cancer cells survive.

Source details

Analysis Breakdown

True/False Spectrum (7.0)Source Credibility (6.0)Bias Assessment (5.0)Contextual Integrity (7.0)Content Coherence (6.0)Expert Consensus (6.0)62%

How to read the breakdown

Weakest areas
Independence5.0/10Source reliability6.0/10
  • Truth: how well sources support the core claim.
  • Source reliability: whether the sources have a strong track record.
  • Independence: whether coverage looks one-sided or recycled.
  • Context: missing details (timeframe, definitions, scope) that change meaning.
  • Tip: if graders disagree, rely more on the summary + sources than the single number.

Detailed AnalysisPremium Feature

Get an in-depth analysis of content accuracy, source credibility, potential biases, contextual factors, claim origins, and hidden perspectives.

Create a free account to unlock premium features.

Methodology